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Abstract
Background: The staphylococci have increasingly been associated with infections worldwide and anti-microbial resistance has 
made these versatile pathogens more recalcitrant in the hospital setting.
Objectives: This study sought to investigate the occurrence and distribution of  Staphylococcus species as well as determine the 
prevalence of  methicillin resistant Staphylococcus aureus (MRSA) and methicillin resistant coagulase negative staphylococci (MRCoNS) 
among clinical samples from University of  Benin Teaching Hospital (UBTH) in Benin City.
Methods: Ninety one (91) clinical isolates comprising S. aureus and Coagulase Negative staphylococci (CoNS) were recovered from 
routine clinical specimens and anti-microbial susceptibility tests were carried out. Polymerase Chain Reaction (PCR) was there-
after carried out on these isolates to detect mecA gene.
Results: Staphylococcus species had its highest prevalence from infected wounds of  patients (28.8%) while urine samples showed 
the least (5.4%). The highest level of  resistance was to ceftazidime (S. aureus - 68%, CoNS - 75.6%) while the least resistance 
was observed for meropenem (S. aureus- 26%, CoNS- 46.3%). Using phenotypic method (with 1µg oxacillin antibiotic disc), the 
distribution of  MRSA and MRCoNS was 44.0% and 46.3% respectively. PCR analysis showed that 38.0% of  S. aureus and 41.5% 
of  the CoNS had mecA gene respectively; wound swabs showed the highest prevalence with 30.5% of  staphylococcal isolates being 
mecA gene positive. There was also no significant association between the Staphylococcal isolates and their isolation rate, isolation 
site and mecA gene distribution (p > 0.05).
Conclusion: This study draws attention on the increase in the prevalence of  mecA gene (39.6%) and an increase in multidrug 
resistant staphylococci when compared to previous studies in our country; it recommends laboratory guidance and periodic review 
to stem the tide of  resistance.
Keywords: Staphylococcus aureus (S. aureus), coagulase-negative staphylococci (CoNS), mecA gene, methicillin-resistance.
DOI: https://dx.doi.org/10.4314/ahs.v17i4.7
Cite as: Ibadin EE, Enabulele IO, Muinah F. Prevalence of  mecA gene among staphylococci from clinical samples of  a tertiary hospital in Benin 
City, Nigeria. Afri Health Sci.2017;17(4): 1000-1010. https://dx.doi.org/10.4314/ahs.v17i4.7
Corresponding author:
Ephraim Ehidiamen Ibadin,
Medical Microbiology Unit, 
Medical Laboratory Services, 




Staphylococcus aureus is a non-motile, aerobic or faculta-
tive anaerobic Gram positive coccus that inhabits the na-
sal membranes and skin of  warm blooded animals and 
man, in whom it could cause a range of  infections from 
mild, such as skin infections and food poisoning, to life 
threatening, such as pneumonia, sepsis, osteomyelitis and 
infectious endocarditis1. The CoNS are part of  the nor-
mal flora of  human skin2, these organisms have relatively 
low virulence but are increasingly recognized as agents 
of  clinically significant infection of  the bloodstream and 
other sites3. Risk factors for CoNS infection include for-
eign bodies (such as indwelling prosthetic devices or in-
travascular catheters) and immune compromise3.
The introduction of  methicillin in 1960 as an alternative 
antibiotic for the treatment of  beta-lactamase (penicilli-
nase) producing S. aureus was greeted with resistance al-
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most immediately4,5.  Since that time, strains of  S. aureus 
resistant to methicillin emerged and became a major clin-
ical problem within hospitals in Europe in the 1960s6, in 
the United States in the 1970s7, and in several countries 
of  the world8. Resistance to methicillin and semisynthet-
ic penicillins has been observed in more than 80% of  
coagulase-negative Staphylococcal isolates9. MRSAs and 
MRCoNS have therefore emerged as the most important 
cause of  hospital-acquired infections (HAI) and com-
munity-acquired infections (CAI), resulting in increased 
morbidity and mortality in the hospital settings10,11.
The specific genetic mechanism of  its resistance in MR-
SAs has been identified as a mobile genetic element 
(staphylococcal cassette chromosome mec) integrated into 
the S. aureus chromosome, within which the mecA gene 
encodes a specific methicillin-resistant transpeptidase 
known as penicillin-binding protein 2a (PBP2a)12. This 
protein has a low affinity for beta-lactam antimicrobial 
drugs, thus bacteria expressing this protein are resistant 
to all types of  these drugs13, and in recent times; amino-
glycosides and quinolones13.
In Nigeria, the occurrence of  MRSA was first document-
ed by researchers in 1987 with its prevalence pegged at 
50.6%14. Subsequent studies have seen a variation in its 
prevalence15,16,17. Literature is growing on CoNS and its 
incrimination in clinical infections in Nigeria18,19; several 
factors affect the reliability of  the disk diffusion technique 
for the detection of  methicilin resistance among the staph-
ylococci17,20. Though molecular methods have emerged as 
the gold standard, there is still little data on the distribu-
tion of  MRSA and MRCoNS in our locality.
This study therefore aims at evaluating the prevalence 
and distribution of  MRSAs and MRCoNS among staph-
ylococci isolated from clinical samples by determining the 
distribution of  mecA gene among these organisms in Be-
nin City using PCR based method.
Materials and methods
Sources of  clinical specimens:
The staphylococci isolates used in this study were obtained 
by serial sampling. Ninety one (91) consecutive non-re-
petitive clinical isolates comprising S. aureus and CoNS 
were recovered from routine clinical specimens sent to 
the diagnostic laboratory of  Medical Microbiology de-
partment, University of  Benin Teaching Hospital, Benin 
city (UBTH).The clinical samples were; wound swabs 
(25), endocervical swabs (4), high vaginal swabs (3), eye 
swabs (4), ear swabs (9), urethral swabs (3), seminal fluid 
(10), blood (17), urine (12), aspirates (2) and urinary cath-
eter tips (2). These specimens were collected from pa-
tients admitted in wards (in-patients), and from patients 
attending out-patient clinics.
Isolation and identification
The isolates were identified to be S. aureus following 
Gram stain that showed Gram positive cocci and biochem-
ical tests which showed positive results for catalase and 
coagulase (slide and/or tube) as described in standard 
Medical Microbiology laboratory manual21. Similarly iso-
lates identified as CoNS were Gram positive cocci and cat-
alase positive but were negative for both slide and tube 
coagulase tests. The isolates were thereafter stored at 4°C 
on Mueller Hinton agar slants for further work.
Antimicrobial susceptibility testing:
In vitro anti-bacterial susceptibility tests were performed 
on each isolate using anti-bacterial drugs. Plates were 
prepared with Mueller Hinton’s agar for use in the Kir-
by-Bauer method. Broth cultures were adjusted to turbid-
ity standard, equivalent to McFarland 0.5. This was then 
used for disc diffusion according to Clinical and Labora-
tory Standard Institute (CLSI) criteria, using the follow-
ing discs; gentamicin (10 µg), ciprofloxacin (5 µg), ofloxa-
cin (5 µg), amoxicillin-clavulanate (30 µg), cefuroxime (30 
µg), ceftriaxone (30 µg) ceftazidime (30 µg), cloxacillin (5 
µg), meropenem (10 µg)  (all from Abtek Biologicals Lt-
d,Liverpool, U.K). These were then incubated at 37˚C for 
18 hrs. Sensitivity pattern was determined by measuring 
the zones of  inhibition with a calibrated ruler and com-
paring with the control organism. Interpretative criteria 
for susceptibility tests were according to CLSI22.
An oxacillin disc (1 µg) was used to detect methicillin re-
sistance. Sensitivity was read after incubation for 24 hrs 
at 35° C. Isolates were regarded as sensitive or resistant 
according to CLSI criteria23.
Multiple antibiotic resistance (MAR) index was calculated 
for each isolate using the formular; 
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Chromosomal DNA Extraction:
DNA extraction was carried out as previously described24; 
Isolates were harvested into 1.0 ml of  sterile water, vor-
texed to mix, and centrifuged at 10,000 r.p.m for 5 min. 
The supernatant was discarded and the pellets were 
washed again with sterile water. After this, 200µl of  sterile 
water was added to the pellets, the pellets were vortexed 
to homogenize, and boiled in a dry bath at 100°C for 10 
minutes. This was followed by vortexing and centrifuga-
tion at 12,000 r.p.m for 5 min. The supernatant contain-
ing the DNA were transferred to another tube and stored 
at -20°C. The concentration and purity of  the extracted 
DNA was estimated using a nanodrop spectrophotome-
ter.
PCR amplification of  mecA gene.
The mecA gene was amplified using the primer set me-
cA1(AAAATCGATGGTAAAGGTTGGC) and mecA2 
(5’AGTTCTGCAGTACCGGATTTTGC3’) as described 
by Del Vechio et al (1995)25. PCR was performed in a 20 
µl of  a reaction mixture containing 1X PCR Buffer (Solis 
Biodyne), 1.5 mM MgCl2, 200 µM of  each dNTP (Solis 
Biodyne), 20 pMol of  each primer, 2.5 units of  TaqD-
NA polymerase (Solis Biodyne),10-200 ng of  extracted 
DNA,  and sterile distilled water was used to make up the 
reaction mixture. Thermal cycling was conducted in an 
Eppendorf  Thermal Cycler Nexus series for an initial de-
naturation of  95°C for 5 min, followed by 30 consecutive 
cycles of  95ºC for 30 sec; 55ºC for 30 sec, and 72ºC for 1 
min. This was followed by a final extension step of  72ºC 
for 10 min. The amplification product was separated on 
1.5% agarose gel electrophoresis, visualized by ethidium 
bromide staining and photographed under Ultraviolet il-
lumination. 100bp DNA ladder (Solis Biodyne) was used 
as DNA molecular weight standard. A single band with a 
molecular weight of  533bp signifies the presence of  the 
mecA gene. S. aureus ATCC 43300 served as the positive 
control strain.
Calculation of  sensitivity and specificity
Calculations of  sensitivity were made by dividing the 
number of  strains detected as resistant by the suscep-
tibility test method by the total number of  strains that 
were mecA positive. Specificity was calculated by dividing 
the number of  strains detected as susceptible by the test 
method by the total number of  strains that were mecA 
negative.
Statistical analysis
Statistical analysis was by the Chi (X2) square test using 




A total of  91 clinical isolates of  Staphylococcus species (S. 
aureus - 50 (54.9%), CoNS - 41 (45.1%)) were recov-
ered from clinical samples during the period of  study. 
Although the isolation rate of  Staphylococcus species was 
higher from males (52.7%), gender was however not a 
risk factor for Staphylococcal infection (X2 = 0.2637, P > 
0.05). There was no significant association in the occur-
rence of  Staphylococci and the isolation sites (X2 = 0.5481, 
P> 0.05).
The isolation rate of  Staphylococcus species from clinical 
samples was highest from infected wounds of  patients 
(28.8%) while urine samples showed the least isolation 
rate (5.4%) as seen in Table 1. 
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Table 1: Distribution of Staphylococcus species recovered from clinical samples. 
 
          Number in parentheses = value in percentage. CoNS- Coagulase negative Staphylococci 
  
Clinical Sample No of Samples No of Culture 
Positive 
samples 
Distribution in clinical 
samples 
S. aureus       CoNS 
Wound Swab 87 62 13 (15.0) 12 (13.8) 
Endocervical 
swab 
35 9 1 (2.9) 3 (8.6) 
High vaginal 
swab 
39 13 2 (5.1) 1 (2.6) 
Eye swab 22 5 2 (9.1) 2 (9.1) 
Ear swab 58 22 6 (10.3) 3 (5.2) 
Urethral swab 19 3 2 (10.5) 1 (5.3) 
Seminal fluid 36 11 9 (25.0) 1 (2.8) 
Blood 65 26 7 (10.8) 10 (15.4) 
Urine 223 89 6 (2.7) 6 (2.7) 
Aspirates 21 4 1 (4.8) 1 (4.8) 
Catheter tip 10 5 1 (6.3) 1 (6.3) 
The anti-microbial susceptibility pattern showed varying 
degrees of  resistance. The highest level of  resistance was 
toceftazidime (S. aureus - 68%, CoNS - 75.6%). The anti-
biotic with the least resistance was meropenem (S. aureus- 
26%, CoNS- 46.3%). The antibiogram is well detailed in 
Table 2. 
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Using phenotypic method (with 1µg oxacillin antibiot-
ic disc), the distribution of  MRSA and MRCoNS was 
44.0% and 46.3% respectively. Multiple antibiotic resis-
tance (MAR) index was calculated for each of  the isolates. 
It was observed that majority of  isolates had MAR indi-
ces of  above 0.2 (S. aureus – 60%, CoNS – 80.5%).
PCR was carried out on all staphylococcal isolates to detect 
mecA gene, a gene that confers resistance to methicillin 
and most β-lactam antibiotics. Figure 1 shows the Aga-
rose gel electrophoresis of  PCR product amplified from 
mecA genes for S. aureus and CoNS. 
Table 2: Antimicrobial Susceptibility Pattern of Staphylococcus species recovered from 
Clinical samples. 
Antibiotics   S. aureus 
n = 50 
  CoNS 
n = 41 
  S R S R 
Oxacillin 28 (56.0) 22 (44.0) 22 (53.7) 19 (46.3) 
Meropenem 37 (74.0) 13 (26.0) 22 (53.7) 19 (46.3) 
Ceftriaxone 27 (54.0) 23 (46.0) 16 (39.0) 25 (61.0) 
Cefuroxime 31 (62.0) 19 (3.8) 19 (46.3) 22 (53.7) 
Ofloxacin 33 (66.0) 17 (34.0) 19 (46.3) 22 (53.7) 
Amoxicillin-
clavulanate 
30 (60.0) 20 (40.0) 21 (51.2) 20 (48.5) 
Cloxacillin 26 (52.0) 24 (48.0) 15 (36.6) 26 (63.4) 
Ceftazidime 16 (32.0) 34 (68.0) 10 (24.4) 31 (75.6) 
Gentamicin 
         28 (56.0)         22 (44.0)          19 (46.3)         22 (53.7) 
Erythromycin 
        28 (56.0)         22 (44.0)          15 (36.6)         26 (63.4) 
    
CoNS- Coagulase negative Staphylococci. S – Sensitive, R – Resistant. Number in parentheses = value in 
percentage. 
 
Table 2: Antimicrobial susceptibilit  p t   l ccus species recovered from 
linical sa ples. 
CoNS- Co gulase negative Staphylococci. S – Sensitive, R – Resistant. u ber parentheses =  
value in percentage. 
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Figure 1: Agarose gel electrophoresis of PCR product amplified from mecAgenes. M = 
DNA marker fragments. Lane 1 was the negative control, Lane 2 was the MRSA positive 
control; S. aureus ATCC 43300, Lane 3, 4, 12, 15, 16, and 17 indicate the mecA positive 
samples.. The DNA fragments of 533 
bp were amplified from mecA gene. 
On the whole, PCR analysis showed that 39.6% of  Staph-
ylococcus species recovered was mecA gene positive with 
38.0% of  S. aureus and 41.5% of  the CoNS having mecA 
gene respectively. mecA gene was markedly distributed 
in wound swabs (30.5%) and was absent in high vaginal 
swabs and catheter tips (Table 4). However, there was no 
significant association between isolation site and the dis-
tribution of  mecA gene among S. aureus (X2 = 0.7735, P 
> 0.05), and CoNS (X2 = 0.4259, P > 0.05). Seventeen 
(17) mecA+ S. aureus were oxacillin resistant (Sensitivity 
89.5%) while 16 mecA+  CoNS were oxacilin resistant 
(Sensitivity 94.1%). Twenty-eight (28) of  the 31 mecA- S. 
aureus strains were oxacilin sensitive (Specificity 90.3%) 
while Nineteen (19) of  the 24 mecA-  CoNS were  oxacil-
lin sensitive (specificity 79.1%).
There was no association between gender and the distri-
bution of  mecA gene among the Staphylococci (S. aureus; X2 
= 0.3253, CoNS; X2 = 0.4205; P > 0.05). Similarly, mecA 
gene did not show significant association for the any one 
of  the Staphylococci (X2 = 0.9604; P >0.05)
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Table 3: Multiple antibiotic resistance (MAR) index of Staphylococcus  
species recovered from clinical samples. 
 
MAR Index S. aureus CoNS 
0.2 5 (16.0) 1(2.8) 
0.3 2 (4.0) 3 (8.3) 
0.4 1 (2.0) 1 (2.8) 
0.5 6 (12.0) 5 (13.8) 
0.6 1 (2.0) 1(2.8) 
0.7 2 (4.0) 4 (11.1) 
0.8 5 (10.0) 3 (8.3) 
0.9 8 (16.0) 7 (19.4) 
1.0 7 (14.0) 8 (22.2) 
Number in parentheses = value in percentage.            CoNS- Coagulase negative Staphylococci 
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Table 4: Distribution of mecA gene among Staphylococcus species from clinical samples 
  
Clinical   
Sample             
                 
  
             
             N             
                              
         S. aureus    
                                   
          
  
         mecA+               
                                   






            
mecA+ 
Wound swab 13 4 (30.7) 12 7 (58.3) 
Endocervical 
swab 
1 0 3 1 (33.3) 
High vaginal 
swab 
2 0 1 0 
Eye swab 2 1 (50.0) 2 0 
Ear swab 6 3 (50.0) 3 2 (66.6) 
Urethral swab 2 1 (50.0) 1 1 (100) 
Seminal fluid 9 5 (55.5) 1 0 
Blood 7 2 (28.5) 10 4 (40.0) 
Urine 6 2 (33.3) 6 1 (16.6) 
Aspirates 1 1 (100) 1 1 (100) 
Catheter tips 1 0   1   0 
Total 50 19 (38.0) 41 17 (41.5) 
CoNS- Coagulase Negative Staphylococci, N = Number of isolates, value in bracket = number in percentages. 
Discussion
In this study, 28.8% of  Staphylococci isolated were from 
wound swabs. In a study which had Staphylococcal iso-
lates recovered from eight hospitals which cut across 
South-Western, North-central and North-Eastern Nige-
ria, more than 80% of  the total number of  S. aureus iso-
lates recovered was from infected wounds13. It has been 
observed that the skin of  80-90% of  people is colonized 
with S. epidermidis and that most CoNS infections are ac-
quired from patients own flora26. The CoNS have also 
shown a higher frequency of  isolation from wound swabs 
when compared to other samples18. In Nigeria, CoNS is 
one of  the common causes of  infections of  open frac-
tures in wounds and delay in wound debridement has 
been reported to be a major predisposing factor to wound 
infection28. Similarly, S. aureus is found on the skin, axilla, 
anterior nares and groins as normal flora27. It is therefore 
not hard to imagine that it would be implicated in wound 
infection as there is a breach in the structural integrity of  
the skin.
Resistance was observed to oxacillin in this study, 44.0% 
and 46.3% for S. aureus and the CoNS respectively. This is 
in contrast to an Iranian study, where resistance was 88% 
and 60.3% for S. aureus and CoNS respectively29. Oxacillin 
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and methicilin are hardly used in our setting as compared 
with the Iranian study which noted the rampant use of  
oxacillin. Our report is however similar to observations 
by Olowe et al in Osogbo, Nigeria, where 40.4% of  S. 
aureus clinical isolates were resistant to oxacillin. Similarly, 
demonstrable levels of  resistance was observed for mero-
penem (S. aureus- 26%, CoNS- 46.3%), though the drug is 
expensive and one of  last resort in our locality30.
The study also shows that majority of  staphylococcal iso-
lates were multidrug resistant, with MAR indices > 0.2 (S. 
aureus – 60%, CoNS – 80.5%).  Worthy of  note is the high 
prevalence of  multidrug resistant CoNS. The finding is 
similar to an observation by Akinjogunla and Enabulele 
(2010). However, in their study on Staphylococcal isolates 
from ear swabs of  patients with otitis media, they found 
that 19.2% of  S. aureus and 9.2% of  CoNS had MAR 
indices above 0.831. An MAR index higher than 0.2 has 
been said to be indicative of  isolates originating from an 
environment where antibiotics were often used32, the high 
indexes from this study therefore give credence to the 
observation of  many researchers in Nigeria on the pre-
vailing practice of  indiscriminate use of  antibiotics and 
lack of  Laboratory guidance before institution of  antimi-
crobial therapy16,17, as they may have induced resistance 
mechanisms over time in these versatile opportunists.
Using PCR method, 38.0% of  S. aureus isolates and 
41.5% of  the CoNS had mecA gene respectively. Using 
phenotypic method (with oxacillin antibiotic disc) how-
ever, the distribution of  MRSA and MRCoNS was 44.0% 
and 46.3% respectively. Differing rates in susceptibility 
pattern has been observed by researchers. Olowe et al in 
drawing comparisons between methicillin, oxacillin, ce-
foxitin and the gold standard PCR, observed that all the 
antibiotics mentioned slightly overestimated methicillin 
resistance in S. aureus30. Hyperproduction of  β-lactamase 
enzyme has been observed among mecA negative MR-
SAs in Nigeria35. Besides the challenge of  heterogeneity 
of  the strains, this could be a resistance mechanism for 
oxacillin-resistant mecA gene negative Staphylococci as ob-
served in this study, more research is therefore needed.
There was no significant association between the dis-
tribution of  Staphylococci and the distribution of  mecA 
gene among clinical samples in this study (P > 0.05), as 
all samples showed some percentage distribution of  the 
gene with the exception of  catheter tips and high vag-
inal swabs. mecA gene was markedly distributed among 
the staphylococci recovered from wound swabs in this study 
(S. aureus-30.7%, CoNS-58.3%). This is comparable to a 
study in Osogbo (S. aureus- 52.2%)30, and two multi-cen-
tre studies evaluating the prevalence of  mecA gene among 
the staphylococci from clinical samples13,17.
Noteworthy in this study is the rising prevalence of  
MRSA and MRCoNS from blood of  patients showing 
signs of  septicaemia, as 28.5% of  S. aureus and 40.0% of  
the CoNS were mecA positive. This is in sharp contrast to 
some studies in Nigeria in which all S. aureus isolated from 
the blood of  patients showing similar symptoms were 
mecA gene negative17,30, however, the gene was detected 
among CoNS notably S. haemolyticusca having septicemia 
in Lagos, Nigeria13. Some researchers have observed the 
rising prevalence of  MRCoNS from patients with septi-
caemia in India; 12% and 54% respectively33, 34.
In our country, little attention has been accorded the 
CoNS to the extent of  screening for mecA gene among 
them. Literature is however growing on its pathogenicity 
and increased isolation from clinical infections18,19. The 
marked distribution of  mecA gene among these isolates 
(41.5%), as well as the insignificant difference in their iso-
lation rate and distribution of  mecA gene when compared 
with S. aureus recovered from clinical samples is a pointer 
to the fact that they should be accorded equal status as 
opportunistic pathogens (P > 0.05).
Conclusion
Summarily, this study notes a rising percentage in the dis-
tribution of  mecA gene among the Staphylococci recovered 
from clinical samples in Benin when compared with pre-
vious studies in our country, it reports increasing level 
of  multidrug resistant staphylococci with high MAR index, 
it reiterates the continued practice of  indiscriminate use 
of  antibiotics and emphasizes laboratory guidance before 
institution of  anti-microbial therapy. Efforts should also 
be made to enact regulations on antibiotic usage. Periodic 
review of  susceptibility pattern, molecular epidemiolog-
ical surveys and surveillance is equally imperative. These 
when implemented promises to stem the tide of  anti-mi 
crobial resistance.
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